Quality of Life Assessed With the PAH SYMPACT Questionnaire

NCT03905421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 390

Last updated 2025-07-25

No results posted yet for this study

Summary

Researchers are evaluating quality of life in pulmonary hypertension subjects using the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire and assessing the questionnaires' performance with regard to relationship to other markers of disease severity, response to treatment, and outcome in a clinical practice setting.

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

Principal Investigators

  • Hilary M DuBrock, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-06
Primary Completion
2024-01-22
Completion
2024-01-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905421 on ClinicalTrials.gov